See the DrugPatentWatch profile for Glycerol
Is there a generic version of glycerol phenylbutyrate?
Glycerol phenylbutyrate is marketed under the brand name Relyvrio. The presence of a “generic” depends on whether any manufacturer has an approved abbreviated pathway product that the FDA allows to be substituted for Relyvrio. To confirm what is available right now (and whether any product is interchangeable at the pharmacy level), you need the latest FDA/Orange Book listing for the exact active ingredient(s) and strength.
What does “generic” mean for glycerol phenylbutyrate specifically?
For prescription drugs, a “generic” can refer to:
- An FDA-approved generic drug with the same active ingredient(s), strength, and dosage form.
- Or, in some cases, a substitute product that may not be labeled as interchangeable for every patient situation.
For glycerol phenylbutyrate, patients usually ask about substitution at the pharmacy counter. That depends on current regulatory status and pharmacy formularies, not just whether the molecule is off-patent.
What strengths and formulations matter when switching to a generic?
Even when a drug is “the same,” substitution can vary by:
- Tablet or oral granule form
- Strength (mg of glycerol phenylbutyrate per dose)
- Dosing schedule and how the drug is taken
If you’re trying to switch from Relyvrio to another product, match the formulation and dose instructions exactly as written by your prescriber.
If there is no generic yet, what are alternatives people look for?
Common alternatives include:
- Brand-to-brand switches within the same molecule family (if products exist)
- Enrollment in patient assistance programs to lower cost
- Financial support programs offered by the manufacturer or third-party foundations
- Taking advantage of insurance coverage tiers or prior authorization pathways
Whether any of these apply depends on your country and insurer.
How to check if a generic is officially available where you live
Use official drug listings:
- For the U.S.: check the FDA Orange Book entry for Relyvrio’s active ingredient(s) and the current applicant list.
- For substitutions: look for FDA “interchangeability” information where available, and confirm with your pharmacist.
If you tell me your country (and whether you mean tablet vs oral formulation, and your dose/strength), I can help you narrow down what “generic” options typically look like and what to check in the relevant regulatory listing.
What to be careful about when switching products
When switching glycerol phenylbutyrate products (even if they’re labeled as the same active ingredient), clinicians and pharmacists typically focus on:
- Dose accuracy and timing
- Side effects that can change if the formulation differs
- Drug interactions and how other medicines are managed alongside it
If you share what you’re taking it for and your current dose, I can flag the kinds of switch-related questions you can ask your prescriber or pharmacist.
---
Sources
No sources were provided in your prompt, so I can’t cite specific regulatory or product-status information. If you share your country (and current brand name, dose, and formulation), I can tailor the guidance to the correct official listings.